Merrimack Pharmaceuticals (MACK)

Add to Watchlists Create an Alert
5.915 +0.20  +3.59% NASDAQ Jul 29, 4:59PM BATS Real time Currency in USD
View Full Chart
MACK Price Chart
View All Events

MACK Events

Date Type Description
05/13/2014 Misc Annual General Meeting for Merrimack Pharmaceuticals Inc
05/01/2014 08:30 EDT Misc Merrimack Pharmaceuticals Inc Q1 2014 Earnings Conference Call
05/01/2014 Earnings Merrimack Pharmaceuticals Inc Q1 2014 Earnings Results. Estimate: -0.31.
02/27/2014 16:30 EST Misc Merrimack Pharmaceuticals Inc Q4 2013 Earnings Conference Call
02/27/2014 Earnings Merrimack Pharmaceuticals Inc Q4 2013 Earnings Results. Estimate: -0.34.
11/07/2013 11:00 EDT Misc Merrimack Pharmaceuticals Announces Timing of Third Quarter 2013 Investor Conference Call
11/07/2013 Earnings Merrimack Pharmaceuticals Announces Timing of Third Quarter 2013 Results. Estimate: -0.34.
08/08/2013 11:00 EDT Misc Merrimack Pharmaceuticals Announces Timing of Second Quarter 2013 Investor Conference Call
08/08/2013 Earnings Second Quarter 2013 Release. Estimate: -0.29.
View All Performance Charts

MACK Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Merrimack Pharmaceuticals is up 22.46% over the last year vs S&P 500 Total Return up 18.90%, Sanofi up 0.53%, and Acorda Therapeutics down 23.40%.

Get Quote for
Advertisement

Portfolio Strategies Featuring MACK

Did Merrimack Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

MACK Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.merrimackpharma.com
  • IR Website: http://investors.merrimackpharma.com/
  • HQ Country: United States
  • HQ State/Province: Massachusetts
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: March 31, 2014
  • Last Fiscal Year End: December 31, 2013
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Merrimack Pharmaceuticals Inc is engaged in discovering, developing and preparing to commercialize medicines consisting of novel therapeutics paired with companion diagnostics for the treatment of cancer.

MACK Excel Add-In Codes

  • Name: =YCI("MACK","name")
  • Description: =YCI("MACK","description")
  • Sector: =YCI("MACK","sector")
  • Industry: =YCI("MACK","industry")
  • Est. Current Fiscal Year End: =YCI("MACK","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{root.upsell.info.tier_name}} Member? Sign in here.